Evidence of mitochondrial dysfunction in ALS and methods for measuring in model systems

Area of Science:

• Neuroscience
• Cell Biology
• Biochemistry

Background:

• Metabolic dysfunction and hypermetabolism are characteristic of amyotrophic lateral sclerosis (ALS) and its models.
• Mitochondria are central to cellular metabolism and ATP generation, but can also produce reactive oxygen species (ROS), contributing to oxidative stress.
• Mitochondria are dynamic organelles involved in various cellular processes, including inter-organelle interactions, fusion/fission, and turnover, all of which can be disrupted.

Purpose of the Study:

• To summarize methods used to assess mitochondrial function in ALS models.
• To review reported alterations in mitochondrial function in ALS models.

Main Methods:

• Assessment of mitochondrial function in cellular and animal models of ALS.
• Analysis of mitochondrial dynamics, including fusion and fission.
• Evaluation of mitochondrial interactions with other organelles, such as the endoplasmic reticulum.
• Measurement of reactive oxygen species (ROS) production by mitochondria.
• Assessment of mitochondrial turnover rates.

Main Results:

• ALS models exhibit significant metabolic dysfunction and hypermetabolism.
• Compromised mitochondrial function, including reduced ATP generation and increased ROS production, is frequently observed.
• Disruptions in mitochondrial dynamics, inter-organelle communication (especially with the ER), and reduced turnover are reported in ALS models.

Conclusions:

• Mitochondrial dysfunction is a key pathological feature in amyotrophic lateral sclerosis.
• Understanding these mitochondrial alterations is crucial for developing therapeutic strategies for ALS.